Article
Spatial dynamics of the tumor microenvironment linked to emerging resistance in <i>EGFR</i> -mutated lung cancer
2025-02-13
Abstract excerpt
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) provide therapeutic benefit in EGFR mutation–positive non–small cell lung cancer, but some individuals develop early resistance. We performed spatial transcriptomics analysis of pre- and posttreatment tumor samples from the same patients to explore the underlying mechanisms of such early resistance. The proportion and activation of fibrobla...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5c099b0f-d3c1-528b-984e-3169a828140f
- DOI
- 10.1101/2025.02.10.637543
